Xenical online research references











  • Impact of carbohydrate and fat intake on weight-reducing efficacy of orlistat.
  • Isolated rat pancreatic acini as a model to study the potential role of lipase in the pathogenesis of acinar cell destruction.
  • Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats.
  • XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.
  • Large spectral changes accompany the conformational transition of human pancreatic lipase induced by acylation with the inhibitor tetrahydrolipstatin.
  • The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase.
  • Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin.
  • Effect of the lipase inhibitor orlistat and of dietary lipid on the absorption of radiolabelled triolein, tri-gamma-linolenin and tripalmitin in mice.
  • Effects of weight reduction programs on close family members.
  • Metabolism of a long-chain diacylglycerol by permeabilized A10 smooth muscle cells.
  • Subcellullar localization, developmental expression and characterization of a liver triacylglycerol hydrolase.
  • Diacylglycerols derived from membrane phospholipids are metabolized by lipases in A10 smooth muscle cells.
  • Tracer studies with crude U-13C-lipid mixtures. Biosynthesis of the lipase inhibitor lipstatin.
  • Behavior of tetrahydrolipstatin in biological model membranes and emulsions.
  • Metabolic fate of exogenous diacylglycerols in A10 smooth muscle cells.
  • Structure and activity of rat pancreatic lipase-related protein 2.
  • Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine
  • Pharmacy-clinics medication of the month. Orlistate (xenical)
  • Asymmetric synthesis of (-)-tetrahydrolipstatin: an anti-aldol-based strategy.
  • The role of orlistat in weight management.
  • Surface behaviour of bile salts and tetrahydrolipstatin at air/water and oil/water interfaces.
  • Role of nonesterified fatty acids in necrotizing pancreatitis: an in vivo experimental study in rats.
  • A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.
  • Treatment in the community health centers in accordance with recommendations of the Medical Products Agency. Unsatisfactory weight reduction with orlistat
  • Roche turns to DM to boost patient compliance with its weight loss drug.
  • Transfer of orlistat through oil-water interfaces.
  • VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass.








    DreamPharm: Herbal and Nutritional supplements online || Hair Million herbal formula for hair loss and hair growth || Antibiotics and prescription medications online literature ||